Cancer doesn’t care, but we do.
With an estimated 28 million new cancer diagnoses expected worldwide each year by 20401, we know we must strive to maximize the impact of our treatments and pioneer novel medicines. Our work in oncology is driven by the belief that we can improve the futures of people living with cancer. Our science of cancer is opening up new possibilities and sparking discovery to explore the full potential of promising mechanisms.
BAVENCIO® (avelumab) Injection 20mg/mL
Learn about our key disease areas and more:
Press Releases
Among patients initially randomized to pimicotinib, improvements in symptoms and joint function were observed as early as Week 5, sustained through two years, and continued to improve over time.
2026/10/26
Press Releases
Abstracts highlight established medicines and investigational candidates across multiple tumor types, including TGCT, CRC, UC, NSCLC, SCCHN, desmoid- and other solid-tumors
2026/10/19
Press Releases
The study is evaluating precemtabart tocentecan (Precem-TcT), a potential first-in-class investigational anti-CEACAM5 ADC, for the treatment of mCRC.
2026/05/21
1 American Cancer Society. What Is Lung Cancer? Available at: https://www.cancer.org/cancer/lung-cancer/about/what-is.html. Accessed May 3, 2021.
